Palatin Technologies CEO Discusses F3Q2011 Results – Earnings Call Transcript – Seeking Alpha

Palatin Technologies CEO Discusses F3Q2011 Results – Earnings Call Transcript
Seeking Alpha
On the next program, I would like to talk about is PL-3994, our natriuretic peptide receptor agonist in development as a treatment for acute exacerbations of asthma. Acute exacerbations of asthma, also called acute severe asthma, is an ongoing asthma
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 ResultsPR Newswire (press release)

all 20 news articles »

View full post on asthma – Google News

EPA Seeking Comments In Tulsa On Proposed Clean Air Plan – News On 6

EPA Seeking Comments In Tulsa On Proposed Clean Air Plan
News On 6
The EPA says exposure to sulfur dioxide can cause respiratory problems like increased asthma and aggravate existing heart disease. Thursday's meeting will be held at the Tulsa Tech, Riverside Campus in the Auditorium of the Alliance Conference Center
EPA says OK needs to clean upKFOR
Oklahoma residents air views on EPA planNewsOK.com
High sulfur dioxide emissions could lead to stronger restrictionsStarNewsOnline.com

all 8 news articles »

View full post on asthma – Google News